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Aquaporin-5 (AQP5) is a water channel protein ex-
pressed in lung, salivary gland, and lacrimal gland epi-
thelia. Each of these sites may experience fluctuations
in surface liquid osmolarity; however, osmotic regula-
tion of AQP5 expression has not been reported. This
study demonstrates that AQP5 is induced by hypertonic
stress and that induction requires activation of extra-
cellular signal-regulated kinase (ERK). Incubation of
mouse lung epithelial cells (MLE-15) in hypertonic me-
dium produced a dose-dependent increase in AQP5 ex-
pression; AQP5 protein peaked by 24 h and returned to
baseline levels within hours of returning cells to iso-
tonic medium. AQP5 induction was observed only with
relatively impermeable solutes, suggesting an osmotic
pressure gradient is required for induction. ERK was
selectively activated in MLE-15 cells by hypertonic
stress, and inhibition of ERK activation with two dis-
tinct mitogen-activated extracellular regulated kinase
kinase (MEK) inhibitors, U0126 and PD98059, blocked
AQP5 induction. AQP5 induction was also observed in
the lung, salivary, and lacrimal glands of hyperosmolar
rats, suggesting potential physiologic relevance for os-
motic regulation of AQP5 expression. This report pro-
vides the first example of hypertonic induction of an
extrarenal aquaporin, as well as the first association
between mitogen-activated protein kinase signaling and
aquaporin expression.
Aquaporin-5 (AQP5)1 is a mammalian water channel protein
that is present in the apical plasma membrane of type I pneu-
mocytes and submucosal glands of the respiratory tract, sali-
vary and lacrimal gland epithelia, and corneal epithelium (1–
3). Aquaporins are important in the functions of these tissues.
Radiation damaged salivary gland function has been partially
restored by viral transfer of an aquaporin gene (4), and AQP5
knockout mice exhibit a reduction in saliva production (5).
Studies of ontogeny and distribution suggest additional roles
for AQP5 in lacrimation, regulation of corneal epithelial hydra-
tion, airway humidification, and generation or maintenance of
the aqueous airway surface layer at multiple sites in the res-
piratory tract (2, 3). At each of the sites at which AQP5 is
expressed, the composition or tonicity of the surface layers may
be acutely altered under both normal (autonomic stimulation)
and pathophysiological conditions; however, the effects of os-
motic stress on AQP5 expression have not been examined.
Investigation of osmotic stress in mammalian tissues has
focused principally on the kidney, in which cells of the renal
medulla may experience levels .1000 mosM in humans (6). In
response to these hypertonic conditions, cells accumulate small
organic molecules, such as betaine, myo-inositol, taurine, and
sorbitol. These “compatible” osmolytes lower cellular ionic
strength, protecting cells from the adverse effects of elevated
intracellular salt concentrations (7). Several studies have dem-
onstrated that genes involved in the synthesis or transport of
compatible osmolytes are activated by hypertonic stress (8–11).
Multiple mitogen-activated protein (MAP) kinase pathways are
activated by osmotic stress in cultured renal cells (12–14).
Specifically, the p38 MAP kinase pathway plays a definitive
role in osmotic induction of both the betaine transporter (beta-
ine/g-amino-n-butyric acid) and the sodium-dependent myo-
inositol transporter (15, 16).
This study was designed to assess the affects of osmotic
stress on AQP5 expression and to identify mechanisms regu-
lating the response. We find that expression of AQP5 protein is
induced by hypertonic stress in cultured mouse lung epithelial
cells and in tissues from hyperosmolar rats. Additionally, we
demonstrate that this induction requires selective activation
and involvement of the ERK MAP kinase pathway. To our
knowledge, these studies provide the first example of osmotic
regulation of a nonrenal aquaporin and also provide the first
evidence that aquaporin expression can be regulated by signal-
ing through MAP kinase pathways.
EXPERIMENTAL PROCEDURES
Materials—Electrophoresis reagents were from Bio-Rad. Reagents
for enhanced chemiluminescence (ECL1) were from Amersham Phar-
macia Biotech. The BCA protein assay kit was from Pierce. TPA and
PD98059 (Calbiochem) were dissolved in Me2SO, as was U0126 (Pro-
mega, Madison, WI). Affinity-purified polyclonal antibodies to the car-
boxyl terminus of rat AQP5 have been described (3). Antibodies to total
ERK (p44/42), total p38, phosphorylated ERK (phospho-p44/42), and
phosphorylated p38 (phospho-p38) were purchased from New England
Biolabs (Beverly, MA). Antibodies to total and phosphorylated JNK
were from Santa Cruz Biotechnology, Inc. Antibody to Na,K-ATPase,
a1-subunit was from Upstate Biotechnology (Lake Placid, NY). Horse
radish peroxidase-coupled secondary antibodies specific for rabbit or
mouse immunoglobulin were from Amersham Pharmacia Biotech. Ex-
cept as specified, all other reagents were from Sigma.
Cell Culture and Drug Treatments—Mouse lung epithelial cells
(MLE-15) (17) were a gift from Dr. Jeff Whitsett (University of Cincin-
nati). MLE-15 cells were grown on untreated culture dishes (Falcon/
Becton Dickenson, Lincoln Park, NJ) at 37 °C with 5% CO2 in HITES
medium: RPMI 1640 medium (Life Technologies, Inc.) supplemented
with insulin transferrin sodium selenite (1⁄10 of a stock vial/500 ml
medium; Sigma), 5 mg/ml transferrin, 10 nM hydrocortisone, 10 nM
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b-estradiol, 10 mM HEPES, 2 mM L-glutamine, 100 units/ml penicillin,
0.1 mg/ml streptomycin, and 2% fetal bovine serum (Life Technologies).
Unless otherwise specified, medium was made hypertonic by adding
200 mosM sorbitol (36.44 mg of sorbitol/ml). In the MAP kinase inhibi-
tion studies, U0126 and PD98059 were added in the specified concen-
tration for a 1-h preincubation before the addition of isotonic or hyper-
tonic medium. Cells were then maintained in the medium for the
duration of the experiment.
Preparation of Cell Extracts and Immunoblotting—Following the
specified incubation, medium was aspirated and cells were washed in
ice-cold phosphate-buffered saline prior to scraping. Scraped cells were
pelleted at 10,000 3 g for 1 min at 4 °C and resuspended in either
ice-cold homogenization buffer for AQP5 immunoblotting (7.5 mM so-
dium phosphate, 1 mM EDTA, 1 mM sodium azide, 0.25 M sucrose, 4
mg/ml leupeptin) or phosphoprotective lysis buffer for MAP kinase
immunoblotting (50 mM b-glycerophosphate (pH 7.2), 0.5% (v/v) Triton
X-100, 0.1 mM sodium vanadate, 2 mM MgCl2, 1 mM EGTA (pH 8.35), 1
mM dithiothreitol, 2 mg/ml leupeptin, 4 mg/ml aprotinin) (18). Cells
resuspended in homogenization buffer were subjected to two rounds of
freeze-thawing followed by vigorous pipeting and then spun at 800 3 g
for 5 min at 4 °C to pellet nuclei and cellular debris. Cells resuspended
in phosphoprotective lysis buffer were incubated on ice for 30 min to
ensure complete lysis and then pelleted at 10,000 3 g for 10 min at 4 °C.
For both homogenization protocols, total protein concentration of the
sample was determined by the BCA assay using the supernatant frac-
tions with bovine serum albumin as standard. 15–50 mg of total protein
in 1.5% (w/v) SDS was loaded per lane on 12% SDS-polyacrylamide gels
and subjected to SDS-PAGE using the buffer system of Laemmli (19).
Duplicate gels were stained with Coomassie Brilliant Blue (Bio-Rad) to
confirm equivalence of samples. Immunoblotting was performed as
described (20) using enhanced chemiluminescence, and blots were vi-
sualized with autoradiography. Antibodies to Na,K-ATPase a1-subunit,
as well as total and phosphorylated MAP kinases, were used according
to the manufacturers’ recommendations. Relative band intensities were
determined by densitometry using a MacBAS bio-imaging analyzer
(version 2.5, Fuji Photo Film Co.).
Northern Blots—Total RNA was isolated from MLE-15 cells using
Trizol Reagent (Life Technologies). RNA concentrations were assessed
spectrophotometrically. 10 mg of total RNA per sample was resolved on
a formaldehyde agarose gel, transferred to nitrocellulose, and hybrid-
ized at high stringency with a full-length rat AQP5 cDNA labeled with
[a-32P]dCTP as described (21). Blots were visualized by autoradiogra-
phy. 18 S ribosomal RNA, visualized by ultraviolet exposure of the
nitrocellulose blot (Eagle Eye Systems, Stratagene, La Jolla, CA), was
used as a loading control.
Animal Protocols—All animal studies were undertaken with proto-
cols approved by the Johns Hopkins School of Medicine Animal Care
and Use Committee. Male Harlan Sprague-Dawley rats (250–300 g;
Harlan Sprague-Dawley, Indianapolis, IN) were used for the animal
studies. Control rats were given daily intraperitoneal injections of ster-
ile isotonic saline (150 mM NaCl; 5 ml/300 g) and allowed free access to
water. Experimental rats were made hyperosmolar using a modifica-
tion of previously described techniques (22); daily intraperitoneal injec-
tions of hypertonic saline (2 M NaCl; 5 ml/300 g) were given for 3 days,
with water restriction for the final 24 h. All rats were euthanized by
CO2 inhalation. The thorax was opened, and an aliquot of blood was
drawn directly from the right ventricle of the heart for subsequent
measurement of serum osmolality by vapor pressure reduction (Wescor
5100C Vapor Pressure Osmometer). The animals were then perfused
through the right and left ventricles with chilled phosphate-buffered
saline until free of blood. Tissue samples were removed, frozen on dry
ice, and stored at –85 °C for subsequent isolation of membranes as
described previously (23). Briefly, tissues were homogenized in a Potter-
Elvehjem homogenizer on ice in homogenization buffer containing 0.25
M sucrose, 1 mM EDTA, 1 mM sodium azide, 1 mM phenylmethylsulfonyl
fluoride, 0.5 mg/ml diisopropyl fluorophosphate, and 4 mg/ml leupeptin.
Homogenates were centrifuged at 800 3 g for 10 min at 4 °C, and the
supernatant was then spun at 200,000 3 g for 30 min at 4 °C. Crude
membrane pellets were solubilized in 1.5% (w/v) SDS, and total protein
concentration was measured. SDS-PAGE and immunoblotting were
performed as described above.
Statistics—Densitometric analysis of protein immunoblots and
Northern blots is expressed as mean 6 S.E. (n $ 3) for each group.
Unpaired t tests were performed for some experiments to assess the
effect of different interventions.
RESULTS
AQP5 Is Induced by Hypertonic Stress in Mouse Lung Epi-
thelial (MLE-15) Cells—Mouse lung epithelial cells (MLE-15)
were incubated in normal medium supplemented with 200
mosM sorbitol (final concentration, 500 mosM), and samples
were harvested at specified times for immunoblot and North-
ern analysis. AQP5 protein increased by 8 h after exposure to
hypertonic medium and peaked at 24 h (Fig. 1, A and B),
whereas AQP5 mRNA peaked by 12 h (Fig. 1C). Following an
initial induction by hypertonic medium (24 h), AQP5 protein
expression was reduced nearly to baseline levels within 6 h
after returning cells to isotonic medium (Fig. 2A, top panel);
AQP5 protein levels continued to be elevated in cells remaining
in hypertonic conditions (Fig. 2A, bottom panel). Similarly,
following a 12 h hypertonic induction, AQP5 mRNA was mark-
edly reduced within 2 h after cells were returned to isotonic
medium (Fig. 2, B and C, lane 2), as compared with mRNA
FIG. 1. Time courses for osmotic induction of AQP5 protein
and mRNA. A, mouse lung epithelial (MLE-15) cells were incubated in
hypertonic medium containing 200 mosM sorbitol. At the designated
times (24c is the 24 h control sample), cells were harvested in homog-
enization buffer for protein immunoblot with affinity-purified anti-
AQP5 antibody (anti-AQP5). B, protein immunoblots from cells treated
as in A (n 5 4 for each group) were analyzed by densitometry and are
represented as a percentage of control at time 0 (mean 6 S.E.; *, p ,
0.05 versus time 0). C, MLE-15 cells were treated as in A and processed
for Northern analysis as described. Relative band intensities (normal-
ized to 18 S rRNA) (n 5 3 for each group) are represented as a percent-
age of control at time 0 (mean 6 S.E.; *, p , 0.05 versus time 0). AQP5
mRNA expression at times 0 and 12 h are shown in the inset.
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expression in cells exposed to hypertonic stress for 12 and 14 h
(Fig. 2, B and C, lanes 1 and 3). To determine whether hyper-
tonic induction of AQP5 was solute-specific, we incubated
MLE-15 cells in medium supplemented with 200 mosM ionic
(NaCl) and nonionic (sorbitol, sucrose, urea, and Me2SO) sol-
utes. AQP5 protein expression was only increased by relatively
impermeable solutes (sorbitol, sucrose, and NaCl), whereas
permeable solutes, such as urea and Me2SO, had little effect on
protein expression (Fig. 3). These data suggest that a hyper-
tonic stimulus (osmotic gradient), not simply hyperosmolarity
(increased solute content), is needed for AQP5 induction.
Dose-response experiments revealed that AQP5 protein was
induced maximally when MLE-15 cells were incubated in me-
dium supplemented with 200 mosM sorbitol (Fig. 4, A and B).
AQP5 was induced to a lesser extent by addition of 300 mosM
sorbitol; however, cell viability was diminished at that level of
osmotic stress. To test potential induction of AQP5 by more
subtle changes in medium osmolarity, MLE-15 cells were incu-
bated in medium with 25, 50, and 100 mosM sorbitol (Fig. 4, C
and D). Addition of 25 mosM sorbitol was sufficient to increase
AQP5 protein expression over that of isotonic controls, and
greater induction was observed as medium osmolarity increased.
AQP5 mRNA Is Not Significantly Stabilized by Hypertonic
Stress—To determine whether stabilization of AQP5 mRNA
accounts for osmotic induction of AQP5 by hypertonicity, cells
incubated in isotonic or hypertonic medium for 12 h were
treated with the transcriptional inhibitor actinomycin D (5 mg/
ml) for the designated times and processed for Northern blotting
(Fig. 5A). Although the overall abundance of AQP5 mRNA was
increased after incubation in hypertonic medium, hypertonicity
did not stabilize the AQP5 mRNA (normalized to 18 S rRNA)
compared with isotonic controls (Fig. 5B; mean of three trials).
ERK Is Activated by Hypertonic Stress in MLE-15 Cells—
Previous reports have shown that all three MAP kinases (ERK,
JNK, and p38) can be activated by osmotic stress (12–14). In
particular, p38 has frequently been implicated in the induction
of genes involved in organic osmolyte synthesis and transport
(15, 16). Therefore, we wanted to determine whether MAP
kinase-mediated signaling was involved in hypertonic induc-
tion of AQP5 in MLE-15 cells. Utilizing antibodies specific for
either the activated (phosphorylated) or total form of each of
the three MAP kinases (ERK, JNK, and p38), we performed
immunoblot analysis on cells incubated in isotonic or hyper-
tonic medium (Fig. 6A). ERK was selectively activated by hy-
pertonic stress in MLE-15 cells; phosphorylated ERK (pERK)
peaked 15 min after hypertonic exposure, increasing by approx-
imately 4-fold (Fig. 6). The total amount of ERK remained
constant, as did the amounts of both phosphorylated and total
JNK and p38 (Fig. 6). Time points were selected based on
previous reports showing activation of MAP kinases within the
first hour after the initial stimulus (24–27).
Specific ERK Pathway Inhibitors Prevent Hypertonic Induc-
tion of AQP5—Because hypertonic stress activated the ERK
pathway but not the JNK or p38 MAP kinase pathways in
MLE-15 cells, we examined the effects of the MEK1/2 inhibi-
tors U0126 and PD98059 on AQP5 induction. MEK1/2 are the
upstream kinases that activate ERK. Both U0126 and
FIG. 2. AQP5 expression decreases when cells are returned to
isotonic medium. A, cells were incubated in control (C) or hypertonic
(H) medium for 24 h and then returned to isotonic medium (top panel)
or maintained in hypertonic medium (bottom panel) for another 3, 6, or
24 h prior to immunoblot analysis. B, Northern blot of cells incubated in
hypertonic medium for 12 h (lane 1), hypertonic medium for 12 h and
returned to isotonic for 2 h (lane 2), and hypertonic medium for 14 h
(lane 3). C, Northern blots from cells treated as in B (n 5 3 for each
group) were analyzed by densitometry and expressed as a percentage of
the mean 12 h time point (mean 6 S.E.; *, p , 0.05 versus 12 h).
FIG. 3. Hypertonic induction of AQP5 by different solutes. A,
MLE-15 cells were incubated in control medium or medium with 200
mosM of ionic (NaCl) and nonionic (sorbitol, sucrose, urea, and Me2SO
(DMSO)) osmolytes for 18–20 h and then processed for immunoblot
analysis as described. B, protein immunoblots from cells treated as in A
(n 5 4 for each group) were analyzed by densitometry and expressed as
a percentage of isotonic control (mean 6 S.E.; *, p , 0.05 versus control).
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PD98059 inhibit MEK1/2; however, their binding affinities and
mechanism of action are distinct (28). U0126 inhibits the ki-
nase activity of MEK1/2, whereas PD98059 blocks activation of
MEK1/2 by Raf kinase. In MLE-15 cells, U0126 and PD98059
both inhibited basal and hypertonicity-induced phosphoryla-
tion of ERK (Fig. 7). U0126 was a more potent inhibitor of ERK
activation, consistent with prior reports (28). Incubation of
MLE-15 cells with either 10 or 50 mM U0126 reduced AQP5
protein induction by hypertonicity but had no effect on basal
AQP5 expression (Fig. 8, A and B). Hypertonic induction of
AQP5 protein was similarly blocked by PD98059 (Fig. 8A,
bottom panel). Incubation of cells with U0126 and PD98059 (50
mM) also reduced hypertonic induction of AQP5 mRNA (Fig.
8C), suggesting potential inhibition at the level of transcrip-
tion. To determine whether the MEK inhibitors were acting
specifically to prevent AQP5 induction, we incubated cells with
U0126 as stated above and probed for Na,K-ATPase (Fig. 8, D
and E), another integral membrane protein known to be in-
duced by hypertonicity (29, 30). In MLE-15 cells, the a-subunit
of Na,K-ATPase was induced nearly 2-fold by hypertonic stress
(Fig. 8, D and E). In contrast to the inhibition of AQP5 induc-
tion, U0126 did not affect expression of Na,K-ATPase, suggest-
ing that reduction of AQP5 by the MEK inhibitors was not a
result of nonspecific effects on total protein synthesis.
ERK Activation Is Necessary but Not Sufficient for AQP5
Induction by Hypertonic Stress—The studies above suggest
that ERK activation is necessary for AQP5 induction by hyper-
tonic stress. To determine whether ERK activation is sufficient
for AQP5 induction, MLE-15 cells were incubated with TPA
(100 nM) under isotonic and hypertonic conditions. TPA is a
potent activator of both protein kinase C and ERK (31). Addi-
tion of TPA to the medium activated ERK (Fig. 9A) but did not
increase basal AQP5 expression, nor did it augment the induc-
tion of AQP5 by hypertonicity (Fig. 9B). Similar results were seen
when 100 nM TPA was incubated with MLE-15 cells for only 1 h
(data not shown), suggesting that the previous findings were not
confounded by chronic inhibition of protein kinase C expression
by TPA (12, 32). These results suggest that ERK activation is
necessary but not sufficient for hypertonic induction of AQP5.
AQP5 Expression Is Induced in Rat Tissues by Hyperosmo-
larity—To investigate whether hypertonic induction of AQP5 can
occur in vivo, AQP5 expression was determined in control and
hyperosmolar rats. As compared with control rats (mean serum
osmolality, 310 6 2.3 milliosmoles/kg; n 5 4), hypertonic animals
FIG. 4. Dose response for hypertonic induction of AQP5. A,
MLE-15 cells were incubated in isotonic or hypertonic medium (supple-
mented with sorbitol as noted) for 20 h and then harvested for immu-
noblot analysis with anti-AQP5 antibody. B, protein immunoblots from
cells treated as in A (n 5 3 for each group) were analyzed by densitom-
etry and represented as a percentage of isotonic control (mean 6 S.E.;
*, p , 0.05 versus control). C, MLE-15 cells were incubated in medium
supplemented with sorbitol as indicated and harvested for immunoblot
analysis with anti-AQP5 antibody. D, relative intensities of the bands
in C are represented as percentages of control (mean 6 S.E.; n 5 3 per
group; *, p , 0.05 versus control).
FIG. 5. AQP5 mRNA is not significantly stabilized by hyper-
tonic stress. A, cells were incubated in either isotonic (top panel) or
hypertonic medium (bottom panel) for 12 h. Actinomycin D (5 mg/ml)
was then added, and cells were harvested at the designated time points
for Northern analysis. B, relative band intensities for isotonic and
hypertonic cells from three separate RNA stability trials were quanti-
tated by densitometry, normalized to the 18 S ribosomal RNA signal for
each sample, and represented as a percentage of the baseline expres-
sion for each group at the indicated times (mean 6 S.E.; n 5 3).
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(mean, 335 6 2.0 milliosmoles/kg; n 5 4) had increased expres-
sion of AQP5 in lung (2-fold), lacrimal gland (7-fold), and sub-
mandibular gland (2-fold) (Fig. 10). These data demonstrate
that hypertonic induction of AQP5 is not an isolated in vitro
phenomenon.
DISCUSSION
Discovery of the aquaporin family of water channel proteins
has provided insight into molecular mechanisms of membrane
water permeability. It is increasingly clear that aquaporins can
be rate-limiting for water transport, as evidenced by recent
demonstrations in the kidney (33, 34), lung (35), and salivary
glands (5). However, with few exceptions, mechanisms regulat-
ing aquaporin expression remain poorly understood. These
studies were undertaken to examine the effects of osmotic
stress on expression of AQP5, an epithelial water channel
found in the apical membrane of type I pneumocytes and sub-
mucosal glands in the respiratory tract, as well as in the apical
membrane of salivary and lacrimal glands and corneal epithe-
lium. In each of these locations, the osmolality of aqueous
surface layers may vary in some circumstances. Here, we de-
scribe that in a lung epithelial cell line, as well as in rat tissues,
AQP5 is up-regulated by hypertonic stress. Osmotic induction
of AQP1 in a kidney cell line was recently described (36). The
studies reported here provide the first example of osmotic in-
duction of a nonrenal aquaporin, as well as the first demon-
stration that aquaporin expression can be regulated by the
MAP kinase signaling cascade.
Upon exposure to hyperosmotic stress, inorganic ions flow
into cells, only to be replaced over several hours by organic
osmolytes, such as betaine and myo-inositol (37). Although
total DNA synthesis, RNA transcription, and protein synthesis
decrease with osmotic stress (38), a limited number of genes
have been identified that are up-regulated (37, 39). Induction of
the transporters and enzymes that facilitate accumulation of
intracellular organic osmolytes has been the focus of intense
investigation (37). Given the intimate relationship of solute
and water transport, we explored whether aquaporin expres-
sion might also be affected by osmotic stress. AQP5 mRNA and
protein were induced by hypertonic stress in MLE-15 cells.
AQP5 mRNA expression peaked at 12 h, whereas protein ex-
pression peaked at 24 h, a time course similar to induction of
organic solute transporters (40). When MLE-15 cells were in-
cubated with hypertonic medium and then returned to isotonic
conditions, AQP5 mRNA and protein expression fell nearly to
baseline levels within hours, indicating that both expression
and degradation may be tightly controlled.
These studies provide the first link between aquaporin ex-
pression and a MAP kinase signaling cascade. MAP kinases
have been implicated in a wide range of cellular events, from
growth factor-mediated proliferation to numerous stress re-
sponses (41, 42). We demonstrate selective activation of ERK
by hypertonic stress in MLE-15 cells. This finding contrasts to
previous studies in alveolar type II cells (31) and inner medul-
lary collecting duct cells (13, 14), in which all three MAP kinase
cascades (ERK, JNK, and p38) are activated by osmotic stress.
Incubation of cells with two distinct MEK inhibitors, U0126
and PD98059, prevented activation of ERK by hypertonic
FIG. 6. ERK is selectively activated relative to other MAP ki-
nases under osmotic stress. A, MLE-15 cells were exposed to control
or hypertonic medium for 15 min and then harvested in phosphopro-
tective buffer. Protein immunoblots were performed using antibody to
either phosphorylated (pERK, pJNK, and pp38) or total (ERK, JNK,
and p38) MAP kinase. B, MLE-15 cells were incubated in hypertonic
medium for the designated time and processed as in A for either phos-
phorylated (top panel) or total (bottom panel) MAP kinase. Immunoblots
were analyzed by densitometry and expressed as a percentage of control
for each MAP kinase (mean 6 S.E.; n 5 4; *, p , 0.05 versus time 0).
FIG. 7. Specific ERK pathway inhibitors prevent both basal
and hypertonicity-induced phosphorylation of ERK. A, MLE-15
cells were treated with isotonic or hypertonic medium for 15 min in the
presence or absence of either U0126 or PD98059 (50 mM) and harvested
in phosphoprotective buffer for immunoblot with anti-pERK antibody.
B, protein immunoblots from cells treated as in A (n 5 3 for each group)
were analyzed by densitometry and expressed as a percentage of iso-
tonic control (mean 6 S.E.; *, p , 0.05 versus hypertonic control).
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stress and dramatically blocked both AQP5 mRNA and protein
induction. Neither basal nor hypertonically induced Na,K-
ATPase expression was affected by these drugs, suggesting
that these inhibitors are not globally affecting protein synthe-
sis pathways.
Although ERK activation is necessary for AQP5 induction in
this model, activation of ERK by TPA did not increase AQP5
expression, either at baseline or following hypertonic stimula-
tion, indicating that additional signaling steps are required.
Signaling events both upstream and downstream from ERK in
this model are currently under investigation. AQP5 was in-
duced only when relatively impermeable solutes were added to
the medium. This requirement for hypertonic, rather than sim-
ply hyperosmolar, stimulation provides some insight into up-
stream events, as it suggests that perturbation of the cell
membrane or cytoskeleton may be necessary for induction to
occur. Downstream ERK is known to activate several transcrip-
tion factors, including Elk1, Ets1, c-Myc, Tal, and STAT, which
then directly activate target genes (42). Our data suggest tran-
scriptional activation of AQP5, because hypertonic stress in-
creased AQP5 mRNA expression severalfold without increas-
ing mRNA stability. This effect may not be direct, however,
based both on the time course of induction (several hours re-
quired) and preliminary studies showing that cyclohexamide
blocks hypertonic induction of AQP5 mRNA (data not shown).
A recently identified hypertonicity-induced transcription fac-
tor, TonEBP (tonicity-responsive element-binding protein)
(43), is a candidate protein for the intermediate in this path-
way. We have been unable to demonstrate activation of a
1.5-kilobase AQP5 proximal promoter by hypertonicity in pre-
liminary experiments (data not shown); however, no tonicity
response element consensus sites are present in this part of the
promoter. Tonicity response elements have been identified as
far as 50 kilobases upstream in the case of sodium-dependent
myo-inositol transporter (44). We suspect that, in a similar
fashion, relevant cis elements in the AQP5 promoter are out-
side of the 1.5-kilobase proximal promoter as well.
We believe that these data strongly support potential in vivo
relevance of this phenomenon for two reasons. First, surface
liquid osmolalities have been demonstrated under some cir-
cumstances to reach 430–480 milliosmoles/kg in human nasal
secretions (45) and canine airway secretions (46, 47). We ob-
served a dose-response relationship for hypertonic induction of
AQP5 beginning with as little as 25 mosM supplemental sorbi-
FIG. 8. ERK pathway inhibitors prevent hypertonic induction of AQP5. A, MLE-15 cells were incubated in isotonic or hypertonic medium
for 18–20 h in the presence or absence of the ERK inhibitors U0126 (10 or 50 mM) or PD98059 (50 mM). Cells were harvested in homogenization
buffer, and protein immunoblots were probed with anti-AQP5. B, protein immunoblots from cells treated as in A (n 5 4 each group) were analyzed
by densitometry and expressed as a percentage of control (mean 6 S.E.; *, p , 0.05 versus hypertonic control). C, cells were treated with U0126
or PD98059 (50 mM) in the presence of hypertonic medium for 12 h and processed for Northern analysis (top panel) with the full-length rat AQP5
cDNA. 18 S ribosomal RNA was utilized as a loading control (bottom panel). D, cells were treated with U0126 as in A, and the immunoblot was
probed for the a-subunit of Na,K-ATPase. E, protein immunoblots from cells treated as in D (n 5 4 for each group) were analyzed by densitometry
and expressed as a percentage of isotonic control (mean 6 S.E.; *, p , 0.05 versus control).
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tol, well within this range. Second, and more importantly,
using previously described techniques for generating hyperos-
molarity in vivo (22), we show that AQP5 was induced in the
lung, submandibular gland, and lacrimal gland of hyperosmo-
lar rats when compared with isosmolar controls. Future inves-
tigation of this phenomenon in additional in vivo models will
allow more specific assessment of the role for hypertonic induc-
tion of AQP5 in different pathophysiologic conditions.
With the recognition that aquaporins can be rate-limiting for
water transport comes an increased need for understanding the
mechanisms regulating their expression, as well as their rele-
vance to human disease. Changes in the tonicity of airway
surface liquid have been implicated in the pathophysiology of
cystic fibrosis (48), as well as in some forms of exercise- or
cold-induced asthma (45, 49, 50). Conditions associated with
increased minute ventilation have been shown to increase air-
way drying and alter surface liquid osmolarity. Likewise, dry
eyes and mouth are common clinical problems; in some pa-
tients the gland dysfunction is immunologically mediated
(Sjogren’s syndrome), although in most, it is not. In all of the
above circumstances, dynamic regulation of AQP5 expression
could be an appropriate response to changes in surface liquid
tonicity, perhaps as a mechanism for restoring lumenal osmo-
larity or maintaining cell volume. Additionally, identification of
ERK as a necessary signaling component in this model pro-
vides the first example linking aquaporin expression to intra-
cellular signaling pathways. Involvement of ERK or other MAP
kinases will likely extend to other models in which aquaporin
expression may be altered, for example with inflammation or
oxidant stress. Identification of both the stimuli and signaling
pathways that regulate aquaporin expression may provide in-
sight into alterations in water transport seen in a wide array of
pathophysiologic conditions.
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